Andrew Hirsch

Director; Director, President & CEO · 2 filings · Latest: Jun 17, 2026

C4 Therapeutics, Inc.

Editas Medicine, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
CCCC	Andrew Hirsch	Director, President & CEO	Feb 15, 2026	Option Exercise	$0.00	20,400	—	1,083,991	Feb 18 10:04 PM
CCCC	Andrew Hirsch	Director, President & CEO	Feb 14, 2026	Option Exercise	$0.00	81,725	—	1,123,145	Feb 18 10:04 PM